 |
市场调查报告书
商品编码
1747754
心臟假体市场按产品类型、最终用户和地区划分Cardiac Prosthetic Devices Market, By Product Type, By End User, and by Region |
||||||
2025 年心臟假体市场规模估计为 89.6 亿美元，预计到 2032 年将达到 167 亿美元，2025 年至 2032 年的复合年增长率为 9.3%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 89.6亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 9.30% | 2032年价值预测 | 167亿美元 |
心臟假体包括机械和组织人工心臟瓣膜、环状成形术环、心律调节器和心臟去颤器导线、组织补片、辅助心臟假体等。这些产品用于替换受损或患病心臟的自体瓣膜。预计在预测期内，高血压的上升将刺激全球心臟假体市场的扩张。研究的增加和产品的推出也有望推动市场扩张。
市场动态
主要市场参与企业正专注于采用各种成长策略，例如产品发布、伙伴关係等，以加强其产品系列和市场地理影响力，预计这将在预测期内推动全球心臟假体市场的成长。例如，2023 年 6 月 8 日，医疗设备製造商雅培发布了其经导管边对边修復 (TEER) 设备 MitraClip 和全球首款微创三尖瓣修復设备 TriClip 的结果数据。这些数据强化了该公司针对二尖瓣和三尖瓣逆流 (MR 和 TR) 的结构性心臟解决方案对广大心臟瓣膜漏出病患小组的效果。
同样，2022 年 10 月，医疗设备公司 Ceryx Medical 宣布与医疗设备公司 Osypka Medical 合作开发一种用于心臟衰竭和其他心臟疾病患者的心臟起搏装置。
此外，医疗设备公司雅培于2022年2月宣布，作为AVEIR DR i2i关键临床试验的一部分，开始在病患中植入其双腔无导线起搏器系统。雅培在临床实验的AVAIR双腔无导线心律调节器的植入代表无导线起搏技术的突破。
本研究的主要特点
- 本报告对全球心臟假体市场进行了详细分析，并提供了预测期 2025-2032 的市场规模和年复合成长率(CAGR)，假设 2024 年为基准年。
- 它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 全球心臟假体市场的主要企业已根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行了分析。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球心臟假体市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员将透过用于分析全球心臟假体市场的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 市场机会
- 影响分析
- 最新产品发布
- 流行病学
- 合併、收购和合作
- 监管情景
- 主要进展
- PEST分析
- 伙伴关係场景
- 品牌与价格分析
- 经销商状况
- 所有类型心臟瓣膜和起搏器的概述
- 波特分析
- 技术进步
- 主要进展
- 市场趋势
- 心臟假体的成长与需求未来前景
- 按收益的顶级市场参与者
4. 全球心臟假体市场-COVID-19影响分析
- 经济影响
- COVID-19流行病学
- 对需求和供给的影响
5. 全球心臟假体市场（依产品类型），2020 年至 2032 年
- 心臟瓣膜
- 起搏器
6. 全球心臟假体市场（依最终使用者划分），2020 年至 2032 年
- 医院
- 专科诊所
- 门诊手术中心
- 其他（学术研究机构等）
7. 全球心臟假体市场（按地区划分），2020 年至 2032 年
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- GCC
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第八章 竞争态势
- Abbott
- Artivion, Inc.
- Medtronic
- Boston Scientific Corporation
- Edwards Lifesciences Corporation.
- Siemens Healthcare Private Limited
- LivaNova PLC（Sorin Group）
- Asahi Kasei Corporation.
- OSYPKA MEDICAL
- Lepu Medical
- MicroPort Scientific Corporation.
- Vitatron
- Koninklijke Philips NV,
- Progetti srl
- Shree Pacetronix Ltd.
第九章 章节
- 调查方法
- 关于出版商
Cardiac Prosthetic Devices Market is estimated to be valued at USD 8.96 Bn in 2025 and is expected to reach USD 16.7 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.96 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.30% | 2032 Value Projection: | USD 16.7 Bn |
Cardiac prosthetic devices include mechanical and tissue prosthetic heart valves, annuloplasty rings, pacemaker and defibrillator leads, tissue patches, artificial hearts, and ventricular assist devices. These are used to replace the heart's native valves that have been harmed or become ill. Over the forecast period, rising levels of hypertension are anticipated to fuel market expansion for cardiac prosthetic devices worldwide. The market is also expected to rise as a result of increased research and product introductions.
Market Dynamics
The key market players are focused on adopting various growth strategies such as product launches, partnerships, and others to strengthen their product portfolio and geographical presence in the market, which in turn is expected to drive the growth of the global cardiac prosthetics devices market over the forecast period. For instance, on June 8, 2023, Abbott, a medical device company, announced result data for MitraClip, which is a transcatheter edge-to-edge repair (TEER) device, and TriClip, a first-of-its-kind minimally invasive tricuspid heart valve repair device. The data reinforce the capabilities of the company's structural heart solutions for both mitral and tricuspid regurgitation (MR and TR) across a broad range of patient groups battling leaky heart valves.
Similarly, in October 2022, Ceryx Medical, a medical device company, in partnership with Osypka Medical, a medical device company, announced the development of a heart-pacing device for patients with heart failure and other cardiac conditions
Furthermore, in February 2022, Abbott, a medical device company, announced the launch of patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker represents technological leadless pacing technology.
Key features of the study
- This report provides an in-depth analysis of the global cardiac prosthetics devices market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac prosthetics devices market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott, Artivion, Inc., Medtronic, Boston Scientific Corporation, Edwards Lifesciences Corporation., Siemens Healthcare Private Limited, LivaNova PLC (sorin group), Asahi Kasei Corporation., OSYPKA MEDICAL, Lepu Medical, MicroPort Scientific Corporation., Vitatron, Koninklijke Philips N.V., Progetti srl and Shree Pacetronix Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Cardiac Prosthetics Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac prosthetics devices market.
Market Segmentation
- Global Cardiac Prosthetic Devices Market, By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented tissue valve
- Stentless tissue valve
- Transcatheter Heart Valves
- Pacemaker
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
- Global Cardiac Prosthetic Devices Market, By End user:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others (Academic & Research Institutes and Others)
- Global Cardiac Prosthetic Devices Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Abbott.
- Artivion, Inc.
- Medtronic
- Boston Scientific Corporation
- Edwards Lifesciences Corporation.
- Siemens Healthcare Private Limited
- LivaNova PLC (Sorin Group)
- Asahi Kasei Corporation.
- OSYPKA MEDICAL
- Lepu Medical
- MicroPort Scientific Corporation.
- Vitatron
- Koninklijke Philips N.V.,
- Progetti srl
- Shree Pacetronix Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End user
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Overview on all types of heart valve and pacemakers
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective on growth and demand of Cardiac Prosthetics Devices
- Top Market Players by Revenue
4. Global Cardiac Prosthetic Devices Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Cardiac Prosthetic Devices Market, By Product Type, 2020 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Heart Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented tissue valve
- Stentless tissue valve
- Transcatheter Heart Valves
- Pacemaker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
- Implantable pacemakers
6. Global Cardiac Prosthetic Devices Market, By End user, 2020 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Others (Academic & Research Institutes and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
7. Global Cardiac Prosthetic Devices Market, By Region, 2020 - 2032, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020 - 2032, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Artivion, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Edwards Lifesciences Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LivaNova PLC (Sorin Group)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Asahi Kasei Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OSYPKA MEDICAL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lepu Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MicroPort Scientific Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vitatron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Progetti srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Shree Pacetronix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
